Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Feb 5;9(2):1104-20.
doi: 10.1021/pr901076y.

Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery

Affiliations

Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery

Brian D Freibaum et al. J Proteome Res. .

Abstract

TDP-43 is a highly conserved and ubiquitously expressed member of the heterogeneous nuclear ribonucleoprotein (hnRNP) family of proteins. Recently, TDP-43 was shown to be a major disease protein in the ubiquitinated inclusions characteristic of most cases of amyotrophic lateral sclerosis (ALS), tau-negative frontotemporal lobar degeneration (FTLD), and inclusion body myopathy. In these diseases, TDP-43 is redistributed from its predominantly nuclear location to ubiquitin-positive, cytoplasmic foci. The extent to which TDP-43 drives pathophysiology is unknown, but the identification of mutations in TDP-43 in familial forms of ALS and FTLD-U suggests an important role for this protein in pathogenesis. Little is known about TDP-43 function and only a few TDP-43 interacting proteins have been previously identified, which makes further insight into both the normal and pathological functions of TDP-43 difficult. Here we show, via a global proteomic approach, that TDP-43 has extensive interaction with proteins that regulate RNA metabolism. Some interactions with TDP-43 were found to be dependent on RNA-binding, whereas other interactions are RNA-independent. Disease-causing mutations in TDP-43 (A315T and M337V) do not alter its interaction profile. TDP-43 interacting proteins largely cluster into two distinct interaction networks, a nuclear/splicing cluster and a cytoplasmic/translation cluster, strongly suggesting that TDP-43 has multiple roles in RNA metabolism and functions in both the nucleus and the cytoplasm. Finally, we found numerous TDP-43 interactors that are known components of stress granules, and indeed, we find that TDP-43 is also recruited to stress granules.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Identification of TDP-43 interacting proteins by FLAG-immunoprecipitation
(A) Immunoprecipitates from FLAG-TDP-43-expressing HEK-293T cells or control HEK-293T cells were separated by gel electrophoresis and stained with Sypro-Ruby to visualize proteins. Both the control and FLAG-TDP-43 lanes were separated into 24 bands along the entire length of the gel and analyzed by mass spectrometry. Intervening empty lanes were removed for visualization purposes. (B) Pie-chart representation of functional classes of TDP-43-interacting proteins.
Figure 2
Figure 2. TDP-43 interacting proteins form two distinct protein interaction networks
TDP-43 proteins identified by mass spectrometry were analyzed using STRING interaction software to identify high confidence interactions using database, literature, and experimental search parameters. Only proteins that were at least two-fold enriched in the TDP-43 immunoprecipitate were analyzed using STRING. Two distinct protein interactions were observed that are labeled as the Nuclear/Splicing Cluster and the Cytoplasmic/Translation Cluster.
Figure 3
Figure 3. The impact of TDP-43 mutations on interactions
(A) Disease-associated mutations do not alter the TDP-43 interactome. The figure shows Sypro-Ruby-stained FLAG immunoprecipitates from control HEK-293T cells, HEK-293T cells expressing wild type FLAG-TDP-43, FLAG-TDP-43 (A315T) or FLAG-TDP-43 (M337V) as indicated. FLAG-TDP-43 (M337V) reproducibly immunoprecipitates less efficiently than either FLAG-TDP-43 or FLAG-TDP-43 (A315T) which is proportional to the decrease in intensity of interacting proteins as visualized by Sypro-Ruby. (B) Some TDP-43 interactions are RNA-dependent. The figure shows Sypro-Ruby-stained FLAG immunoprecipitates from control HEK-293T cells, HEK-293T cells expressing wild type FLAG-TDP-43, wild type FLAG-TDP-43 (treated with RNase A), or FLAG-TDP-43 (mutRRM), as indicated. Immunoprecipitation was repeated at least three times with consistent results. Representative images were chosen for display.
Figure 4
Figure 4. Characterization of TDP-43 interaction with hnRNP H and PABPC1
(A) Validation of TDP-43 interaction with hnRNP H and PABPC1 by co-immunoprecipitation followed by Western blot analysis in HEK-293T cells. Left panel: Western blot analysis of whole cell lysates prior to immunoprecipitation was used to visualize 1% of protein input. Right panel: Western blot analysis of FLAG immunoprecipitates. Quantification was performed using Image J (shown below each band) and normalized to the amount of TDP-43 in lane 2. Immunoprecipitation was repeated at least three times with consistent results and representative images were chosen for display. (B) Immunofluorescence was used to visualize the localization of TDP-43 and hnRNP H in HeLa cells. DAPI staining was used to visualize the nucleus. TDP-43 and hnRNP H both showed pan-nuclear expression with co-localization in sub-nuclear foci in HeLa cells. The immunofluorescence data shown represents consistent results obtained in multiple replicates. IB: immunoblot, IP: immunoprecipitation.
Figure 5
Figure 5. Cytoplasmic TDP-43 is localized in stress granules
Immunofluorescence was used to visualize the localization of exogenous (A-C) FLAG-TDP-43 or endogenous (D) TDP-43 and (A) PABPC1, (B, D) G3BP1 and (C) EIF4G in HeLa cells. DAPI staining was used to visualize the nucleus. TDP-43 was found to localize with stress granules in the cytoplasm of HeLa cells. (D) After treatment with 50 μM MG-132 for 3 hours, RNA granules were observed in 66% of cells. At least 1 TDP-43 positive stress granule was observed in 25% of cells after MG-132 treatment. 300 HeLa cells were counted. All of the immunofluorescence data shown represents consistent results obtained in multiple replicates.
Figure 6
Figure 6. TDP-43 association with stress granules is strongly mitigated by inability to bind RNA
(A) TDP-43(mutRRM) was rarely found in cytoplasmic RNA granules (as visualized by EIF4G). (B) In FLAG-TDP-43 expressing cells, FLAG-TDP-43 was found to co-localize with EIF4G in 85% of stress granules (n=242 cells) whereas FLAG-TDP-43(mutRRM) was found in only 6.5% of stress granules (n=168 cells).

Similar articles

Cited by

References

    1. Ou SH, Wu F, Harrich D, Garcia-Martinez LF, Gaynor RB. Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs. J Virol. 1995;69(6):3584–96. - PMC - PubMed
    1. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM, McCluskey LF, Miller BL, Masliah E, Mackenzie IR, Feldman H, Feiden W, Kretzschmar HA, Trojanowski JQ, Lee VM. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314(5796):130–3. - PubMed
    1. Neumann M, Mackenzie IR, Cairns NJ, Boyer PJ, Markesbery WR, Smith CD, Taylor JP, Kretzschmar HA, Kimonis VE, Forman MS. TDP-43 in the ubiquitin pathology of frontotemporal dementia with VCP gene mutations. J Neuropathol Exp Neurol. 2007;66(2):152–7. - PubMed
    1. Geser F, Martinez-Lage M, Kwong LK, Lee VM, Trojanowski JQ. Amyotrophic lateral sclerosis, frontotemporal dementia and beyond: the TDP-43 diseases. J Neurol. 2009;256(8):1205–14. - PMC - PubMed
    1. Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, Rogelj B, Ackerley S, Durnall JC, Williams KL, Buratti E, Baralle F, de Belleroche J, Mitchell JD, Leigh PN, Al-Chalabi A, Miller CC, Nicholson G, Shaw CE. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science. 2008;319(5870):1668–72. - PMC - PubMed

Publication types

Substances